Our inability to predict thromboembolic events after prosthetic valve surgery

Journal of Heart Valve Disease

Volumn 15, Issue 4, 2006, Pages 570-580

  Will, Malcolm B ^a   Bernacca, Gillian M ^a   Bell, Elizabeth F ^a   Tolland, Margaret M ^a   Lowe, Gordon D O ^a   Rumley, Ann ^a   Murray, Heather M ^a   Ford, Ian ^a   Wheatley, David J ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRIN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ANTICOAGULATION; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; ELECTIVE SURGERY; EQUIPMENT DESIGN; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VALVE BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; UNITED KINGDOM;

AGED; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTERVIEWS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; QUESTIONNAIRES; REFERENCE VALUES; RISK ASSESSMENT; SURGICAL PROCEDURES, ELECTIVE; THROMBOEMBOLISM; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VON WILLEBRAND FACTOR;

EID: 33746399368     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Grunkemeier GL, Li H-H, Naftel DC, Starr A, Rahimtoola SH. Long-term performance of heart valve prostheses. Curr Probl Cardiol 2000;25:75-154
2. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995;25:1111-1119
3. Butchart EG. Rationalizing antithrombotic management for patients with prosthetic heart valves. J Heart Valve Dis 1995;4:106-113
4. Mistiaen W, Van Cauwelaert Ph, Muylaert Ph, Sys SU, Harrisson F, Bortier H. Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg 2004;127:1166-1170
5. Butchart EG, Ionescu A, Payne N, Giddings J, Grunkemeier GL, Fraser AG. A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 2003;108(Suppl.1):II68-II74
6. Butchart EG, Moreno de la Santa P, Rooney SJ, Lewis PA. Arterial risk factors and ischemic cerebrovascular events after aortic valve replacement. J Heart Valve Dis 1995;4:1-8
7. Butchart EG. Fibrinogen and leukocyte activation - the keys to understanding prosthetic valve thrombosis? J Heart Valve Dis 1997;6:9-16
8. Van Wersch JWJ, Van Mourik-Alderliesten CH, Coremans A. Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation. Blood Coag Fibrinolysis 1992;3:183-186
9. Giansante C, Fiotti N, Calabrese S, et al. D-dimer and anticoagulation in patients with mechanical prosthetic heart valves: A 2-year follow-up. Arterioscler Thromb Vasc Biol 1997;17:1320-1324
10. Lowe GDO, Yarnell JWG, Sweetnam P, Rumley A, Elwood PC. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor and risk of major ischaemic heart disease events in the Caerphilly Heart Study. Thromb Haemost 1998;79:129-133
11. Smith FB, Lee AJ, Fowkes FGR, Price JF, Rumley A, Lowe GDO. Haemostatic factors as predictors of ischaemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997;17:3321-3325
12. Dalinin V, Lingaas PS, Hatteland K, Svennevig JL. Carotid Doppler microembolic signals in patients one year after heart valve surgery. Perfusion 2003;18:333-337
13. Nadareishvili ZG, Beletsky V, Black SE, et al. Is cerebral microembolism in mechanical prosthetic heart valves clinically relevant? J Neuroimaging 2002;12:310-315
14. Sliwka U, Georgiadis, D. Clinical correlations of Doppler microembolic signals in patients with prosthetic cardiac valves: Analysis of 580 cases. Stroke 1998;29:140-143
15. Braekken SK, Russell D, Brucher R, Svennevig J. Incidence and frequency of cerebral embolic signals in patients with a similar bileaflet mechanical heart valve. Stroke 1995;26:1225-1230
16. Shaw M, Smith GD, Dorling D. Health inequalities and New Labour: How the promises compare with the real thing. Br Med J 2005;330:1016-1021
17. Mitchell R, Fowkes G, Blane D, Bartley M. High rates of ischaemic heart disease in Scotland are not explained by conventional risk factors. J Epidemiol Community Health 2005;59:565-567
18. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller C, Weisel RD. Guidelines for Reporting Morbidity and Mortality after Cardiac Valvular Operations. Ann Thorac Surg 1996;62:932-935
19. Sturzenegger M, Beer JH, Rihs, F. Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers. Stroke 1995;26:63-69
20. Spencer MP, Ackerstaff RGA, Babikian VL, et al. Basic identification criteria of Doppler microembolic signals. Stroke 1995;26:1123
21. Wheatley DJ, Tolland MM, Pathi V, et al. Randomised prospective evaluation of a new pericardial heart valve: Outcome after seven years. Eur J Cardiothorac Surg 1995;9:259-268
22. Huber KC, Gersh BJ, Bailey KR, et al. Variability in anticoagulation control predicts thromboembolism after mechanical cardiac valve replacement: A 23-year population-base study. Mayo Clin Proc 1997;72:1103-1110
23. Butchart EG, Payne N, Li H-H, Buchan K, Mandana K, Grunkemeier GL. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 2002;123:715-723
24. Ansell J, Jacobson A, Levy J, Voller H, Hasenkam JM. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol 2005;99:37-45
25. Wittkowsky AK, Sekreta CM, Nutescu EA, Ansell J. Barriers to patient self-testing of prothrombin time: National survey of anticoagulation practitioners. Pharmacotherapy 2005;25:265-269
26. Christensen TD, Andersen NT, Attermann J, Hjortdal VE, Maegaard M, Hasenkam JM. Mechanical heart valve patients can manage oral anticoagulant therapy themselves. Eur J Cardiothorac Surg 2003;23:292-298
27. Woodburn KR, Rumley A, Lowe GDO, Love JG, Murray GD, Pollock JG. Clinical, biochemical and rheologic factors affecting the outcome of infrainguinal bypass grafting. J Vasc Surg 1996;24:639-646
28. Deklunder G, Roussel M, Lecroart J-L, Prat A, Gautier C. Microemboli in cerebral circulation and alteration of cognitive abilities in patients with mechanical prosthetic heart valves. Stroke 1998;29:1821-1826
29. Geiser T, Sturzenegger M, Genewein U, Haeberli A, Beer J. Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli, and platelet microparticles in patients with prosthetic heart valves. Stroke 1998;29:1770-1777
30. Georgiadis D, Mallinson A, Grosset DG, Lees KR. Coagulation activity and emboli counts in patients with prosthetic cardiac valves. Stroke 1994;25:1211-1214
31. Kaps M, Hansen J, Weiher M, Tiffert K, Kayser I, Droste DW. Clinically silent microemboli in patients with artificial prosthetic aortic valves are predominantly gaseous and not solid. Stroke 1997;28:322-325
32. Mackay TG, Georgiadis D, Grosset DG, Kelman AW, Lees KR, Wheatley DJ. Transcranial Doppler ultrasound signals associated with prosthetic heart valves: An in vitro study. J Heart Valve Dis 1995;4:414-419
33. Wheatley DJ, Raco L, Bernacca GM, Sim I, Belcher PR, Boyd JS. Polyurethane: Material for the next generation of heart valve prostheses? Eur J Cardiothorac Surg 2000;17:440-447